Peptide comedy accounts and what they get wrong about BPC-157

What did @50percentnatty actually say?

The creator's core claim is simple enough: "I don't take steroids, just SARMs and peptides." The joke, obviously, is that this distinction doesn't exactly scream "natty." But underneath the comedy is a real argument a lot of gym-goers make in earnest, that SARMs and peptides occupy some separate, cleaner category from anabolic steroids. That framing deserves scrutiny.

The transcript is garbled by auto-caption errors, but the meaning is clear. The creator is defending a "half natty" identity by drawing a line between steroids on one side and SARMs plus peptides on the other. Whether that line is scientifically meaningful is a different question entirely.

Does the science back this up?

Not really, at least not in the way the claim implies. SARMs, or selective androgen receptor modulators, bind to the same androgen receptors that anabolic steroids target. They are chemically distinct from testosterone and its derivatives, yes, but calling them a clean alternative is a stretch the evidence does not support.

A 2023 review published in Drugs (Bhasin et al.) confirmed that SARMs produce dose-dependent increases in lean mass and suppress endogenous testosterone production, the same two defining effects people associate with steroids. The FDA has issued multiple warnings noting SARMs are linked to liver toxicity, cardiovascular risk, and infertility. Peptides are a broader category. Some, like ipamorelin or CJC-1295, stimulate growth hormone release indirectly and have a meaningfully different mechanism than anabolic steroids. BPC-157 operates through different pathways entirely. Lumping all peptides together with SARMs as a single "not-steroid" category is imprecise at best.

What did they get wrong (or right)?

They got the chemistry technically right. SARMs are not classified as anabolic-androgenic steroids under current pharmacological definitions. Peptides, as a class, are also distinct from synthetic androgens. So in a narrow, literal reading, the claim holds up.

What they got wrong is the implied safety and legitimacy gap. The distinction "just SARMs and peptides" carries an undertone of "therefore less concerning," and that does not hold. SARMs remain unapproved by the FDA for any medical use as of 2024. A 2020 study in JAMA Network Open (Cohen et al.) found that products sold as SARMs online frequently contained unlisted steroids, no active compound at all, or dangerous adulterants. The regulatory and safety picture for SARMs is arguably messier than for pharmaceutical-grade testosterone, not cleaner.

On peptides, the picture is more mixed. Some peptides have legitimate research behind them for specific applications. But that research does not justify the casual framing of peptides as a consequence-free category.

What should you actually know?

The "SARMs aren't steroids" argument is real but incomplete. Here is what the evidence actually supports:

• SARMs bind androgen receptors and suppress the hypothalamic-pituitary-gonadal axis. Testosterone suppression is documented across multiple compounds including ostarine (enobosarm) and ligandrol (LGD-4033).
• Peptides vary enormously. Growth hormone secretagogues like ipamorelin work through ghrelin receptors and have a distinct mechanism. Tissue-repair peptides like BPC-157 have shown promise in animal models, but human clinical trial data remains limited as of 2024.
• "Not a steroid" does not mean FDA-approved, clinically validated, or free of side effects. It is a chemical classification, not a safety endorsement.
• Anyone considering peptide therapy through a regulated telehealth provider should have a full hormone panel and medical evaluation first. These are not over-the-counter supplements.

The creator is clearly playing this for laughs, and that context matters. But 77,500 viewers include people who will take the underlying framing seriously. The science says the "natty" line is murkier than the bit implies.